Conditions: Hemodialysis Hyperphosphatemia
Keywords: Hemodialysis Hyperphosphatemia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate the safety and efficacy when administering PA21 with calcium carbonate in hemodialysis patients with hyperphosphatemia for 12 weeks.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: PA21
Intervention descriptions: intervention 1: None

Protocol document: